| Date Checked | 2026-04-21 03:17:14 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | ABSI |
| AssetType | Common Stock |
| Name | Absci Corp |
| Description | Absci Corp (ABSI) is a pioneering biotechnology company revolutionizing drug discovery through its state-of-the-art AI-driven biology platform. Focused on the rapid generation of high-quality proteins and therapeutic candidates, Absci significantly accelerates traditional development timelines while lowering associated costs. The company is dedicated to transforming the biopharmaceutical landscape by equipping partners with innovative tools to develop and manufacture next-generation therapies with unparalleled efficiency and precision. With a robust pipeline of collaborations and proprietary initiatives, Absci is strategically positioned to drive significant advancements in disease treatment and modern drug development practices. |
| CIK | 1672688 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 18105 SE MILL PLAIN BOULEVARD, VANCOUVER, WA, UNITED STATES, 98683 |
| OfficialSite | https://www.absci.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 452618000 |
| EBITDA | -105502000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 1.405 |
| DividendPerShare | None |
| EPS | -0.91 |
| RevenuePerShareTTM | 0.022 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -79.77 |
| ReturnOnAssetsTTM | -0.306 |
| ReturnOnEquityTTM | -0.557 |
| RevenueTTM | 2815000 |
| GrossProfitTTM | -70233000 |
| DilutedEPSTTM | -0.91 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.778 |
| AnalystTargetPrice | 8.05 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 6 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 156.82 |
| PriceToBookRatio | 2.123 |
| EVToRevenue | 106.7 |
| EVToEBITDA | -0.391 |
| Beta | 2.13 |
| 52WeekHigh | 5.23 |
| 52WeekLow | 2.01 |
| 50DayMovingAverage | 2.82 |
| 200DayMovingAverage | 3.085 |
| SharesOutstanding | 150372000 |
| SharesFloat | 132378000 |
| PercentInsiders | 13.522 |
| PercentInstitutions | 77.694 |
| ExDividendDate | None |
| etoro | 1 |
| dateChecked | 2026-04-21 03:17:14 |
| fresh | 1 |